Kuwait City : On Friday, Pfizer and BioNTech announced that they will submit a request to the US Food and Drug Administration for Emergency Use Authorization of their coronavirus vaccine. In a statement, Pfizer said that "This will potentially enable use of the vaccine in high-risk populations in the US by the middle to end of December 2020." Dr Albert Bourla, Chairman and CEO of Pfizer said that "Our work to deliver a safe and effective vaccine has never been more urgent, as we continue to see an alarming rise in the number of cases of Covid-19 globally," Also he added that "Filing in the US represents a critical milestone in our journey to deliver a Covid-19 vaccine to the world and we now have a more complete picture of both the efficacy and safety profile of our vaccine, giving us confidence in its potential." CEO and Co-Founder of BioNTech Ugur Sahin said filing for the EUA in the US is a critical step in making our vaccine candidate available to the global population as quickly as possible,"
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Velit omnis animi et iure laudantium vitae, praesentium optio, sapiente distinctio illo?